Valuation: Bayer AG

Market Cap 4.52TCr 5.05TCr 4.17TCr 3.78TCr 7.06TCr 4,80800Cr 7.17TCr 50TCr 20TCr 2,51600Cr 19TCr 19TCr 7,96900Cr P/E 2026 *
19.5x
P/E 2027 * 14.6x
Enterprise Value 7.49TCr 8.36TCr 6.91TCr 6.25TCr 12TCr 7,96200Cr 12TCr 82TCr 33TCr 4,16700Cr 31TCr 31TCr 13,19800Cr EV / Sales 2026 *
1.63x
EV / Sales 2027 * 1.52x
Free-Float
99.99%
Yield 2026 *
0.3%
Yield 2027 * 1.21%
1 day+3.92%
1 week+8.48%
Current month+0.02%
1 month-1.88%
3 months+0.57%
6 months+31.58%
Current year+29.59%
1 week 43.31
Extreme 43.31
47.96
1 month 42.56
Extreme 42.56
49.68
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Buy

Director

1,900 0.0002%
18/03/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/03/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+4.19%+8.48%+74.02%+17.90% 5.04TCr
+5.99%+4.50%+67.84%+141.37% 1,14800Cr
+1.25%+2.46%+46.94%+86.49% 65TCr
+0.92%+1.29%+28.30%+103.58% 51TCr
+0.73%+2.45%+54.26%+66.47% 38TCr
+3.57%-0.66%+68.93%+42.44% 35TCr
+2.38%+2.65%+34.31%+56.33% 29TCr
+2.26%+0.55%+3.92%+27.74% 26TCr
+1.58%+2.74%+57.51%+74.61% 24TCr
+1.50%+2.74%+36.29%+107.66% 20TCr
Average +2.44%+1.56%+47.23%+72.46% 40.88TCr
Weighted average by Cap. +2.92%+1.52%+49.84%+91.90%

Financials

2026 *2027 *
Net sales 4.59TCr 5.12TCr 4.23TCr 3.83TCr 7.16TCr 4,87700Cr 7.28TCr 50TCr 20TCr 2,55200Cr 19TCr 19TCr 8,08300Cr 4.71TCr 5.25TCr 4.34TCr 3.93TCr 7.35TCr 5,00200Cr 7.46TCr 52TCr 21TCr 2,61800Cr 20TCr 19TCr 8,29200Cr
Net income 229.69Cr 256.44Cr 211.9Cr 191.76Cr 358.57Cr 24TCr 364.37Cr 2.53TCr 1.01TCr 13TCr 962.38Cr 941.89Cr 40TCr 302.44Cr 337.65Cr 279.02Cr 252.49Cr 472.14Cr 32TCr 479.77Cr 3.33TCr 1.33TCr 17TCr 1.27TCr 1.24TCr 53TCr
Net Debt 2.97TCr 3.31TCr 2.74TCr 2.48TCr 4.63TCr 3,15500Cr 4.71TCr 33TCr 13TCr 1,65100Cr 12TCr 12TCr 5,22900Cr 2.64TCr 2.95TCr 2.44TCr 2.21TCr 4.13TCr 2,81100Cr 4.19TCr 29TCr 12TCr 1,47100Cr 11TCr 11TCr 4,65900Cr
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
29/26/29 €47.96 +4.19% 26,63,810
28/26/28 €46.03 -0.26% 17,86,980
27/26/27 €46.15 +1.29% 18,01,210
26/26/26 €45.56 +3.59% 19,64,992
23/26/23 €43.98 -0.52% 11,83,777
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
46.03EUR
Average target price
58.33EUR
Spread / Average Target
+26.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bayer AG
  1. Stock Market
  2. Stocks
  3. BAYN Stock